Skip to main content
PMC home page
Journal of Bacteriology logoLink to Journal of Bacteriology
. 1997 Nov;179(22):7004–7010. doi: 10.1128/jb.179.22.7004-7010.1997

Use of steroids to monitor alterations in the outer membrane of Pseudomonas aeruginosa.

P Plesiat 1, J R Aires 1, C Godard 1, T Köhler 1
PMCID: PMC179640  PMID: 9371446

Abstract

Testosterone (a strongly hydrophobic steroid) and testosterone hemisuccinate (a negatively charged derivative) were used as probes to investigate alterations in the outer membrane of Pseudomonas aeruginosa. Diffusion rates of the steroids across the lipid bilayer were measured by coupling the influx of these compounds to their subsequent oxidation by an intracellular delta1-dehydrogenase enzyme. Wild-type cells of P. aeruginosa (strain PAO1) were found to be 25 times more permeable to testosterone than to testosterone hemisuccinate. The uptake of the latter compound appeared to be partially dependent on the external pH, thus suggesting a preferential diffusion of the uncharged protonated form across the cell envelope. Using various PAO mutants, we showed that the permeation of steroids was not affected by overexpression of active efflux systems but was increased up to 5.5-fold when the outer membrane contained defective lipopolysaccharides or lacked the major porin OprF. Such alterations in the hydrophobic uptake pathway were not, however, associated with an enhanced permeability of the mutants to the small hydrophilic molecule N,N,N',N'-tetramethyl-p-phenylene diamine. Thirty-six agents were also assayed for their ability to damage the cell surface of strain PAO1, using testosterone as a probe. Polymyxins, rBPI23, chlorhexidine, and dibromopropamidine demonstrated the strongest permeabilizing activities on a molar basis in the presence of 1 mM MgCl2. These amphiphilic polycations increased the transmembrane diffusion of testosterone up to 50-fold and sensitized the PAO1 cells to hydrophobic antibiotics. All together, these data indicated that the steroid uptake assay provides a direct and accurate measurement of the hydrophobic uptake pathway in P. aeruginosa.

Full Text

The Full Text of this article is available as a PDF (412.4 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Angus B. L., Fyfe J. A., Hancock R. E. Mapping and characterization of two mutations to antibiotic supersusceptibility in Pseudomonas aeruginosa. J Gen Microbiol. 1987 Oct;133(10):2905–2914. doi: 10.1099/00221287-133-10-2905. [DOI] [PubMed] [Google Scholar]
  2. Beamer L. J., Carroll S. F., Eisenberg D. Crystal structure of human BPI and two bound phospholipids at 2.4 angstrom resolution. Science. 1997 Jun 20;276(5320):1861–1864. doi: 10.1126/science.276.5320.1861. [DOI] [PubMed] [Google Scholar]
  3. Bellido F., Martin N. L., Siehnel R. J., Hancock R. E. Reevaluation, using intact cells, of the exclusion limit and role of porin OprF in Pseudomonas aeruginosa outer membrane permeability. J Bacteriol. 1992 Aug;174(16):5196–5203. doi: 10.1128/jb.174.16.5196-5203.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Berry D., Kropinski A. M. Effect of lipopolysaccharide mutations and temperature on plasmid transformation efficiency in Pseudomonas aeruginosa. Can J Microbiol. 1986 May;32(5):436–438. doi: 10.1139/m86-082. [DOI] [PubMed] [Google Scholar]
  5. Coyne M. J., Jr, Russell K. S., Coyle C. L., Goldberg J. B. The Pseudomonas aeruginosa algC gene encodes phosphoglucomutase, required for the synthesis of a complete lipopolysaccharide core. J Bacteriol. 1994 Jun;176(12):3500–3507. doi: 10.1128/jb.176.12.3500-3507.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Dasgupta T., de Kievit T. R., Masoud H., Altman E., Richards J. C., Sadovskaya I., Speert D. P., Lam J. S. Characterization of lipopolysaccharide-deficient mutants of Pseudomonas aeruginosa derived from serotypes O3, O5, and O6. Infect Immun. 1994 Mar;62(3):809–817. doi: 10.1128/iai.62.3.809-817.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Day C. A., Marceau-Day M. L., Day D. F. Increased susceptibility of Pseudomonas aeruginosa to ciprofloxacin in the presence of vancomycin. Antimicrob Agents Chemother. 1993 Nov;37(11):2506–2508. doi: 10.1128/aac.37.11.2506. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Farmer S., Li Z. S., Hancock R. E. Influence of outer membrane mutations on susceptibility of Escherichia coli to the dibasic macrolide azithromycin. J Antimicrob Chemother. 1992 Jan;29(1):27–33. doi: 10.1093/jac/29.1.27. [DOI] [PubMed] [Google Scholar]
  9. Fukuda H., Hosaka M., Hirai K., Iyobe S. New norfloxacin resistance gene in Pseudomonas aeruginosa PAO. Antimicrob Agents Chemother. 1990 Sep;34(9):1757–1761. doi: 10.1128/aac.34.9.1757. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. García-Horsman J. A., Barquera B., Rumbley J., Ma J., Gennis R. B. The superfamily of heme-copper respiratory oxidases. J Bacteriol. 1994 Sep;176(18):5587–5600. doi: 10.1128/jb.176.18.5587-5600.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Gazzano-Santoro H., Parent J. B., Grinna L., Horwitz A., Parsons T., Theofan G., Elsbach P., Weiss J., Conlon P. J. High-affinity binding of the bactericidal/permeability-increasing protein and a recombinant amino-terminal fragment to the lipid A region of lipopolysaccharide. Infect Immun. 1992 Nov;60(11):4754–4761. doi: 10.1128/iai.60.11.4754-4761.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Gotoh N., Wakebe H., Yoshihara E., Nakae T., Nishino T. Role of protein F in maintaining structural integrity of the Pseudomonas aeruginosa outer membrane. J Bacteriol. 1989 Feb;171(2):983–990. doi: 10.1128/jb.171.2.983-990.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Groen B. W., van Kleef M. A., Duine J. A. Quinohaemoprotein alcohol dehydrogenase apoenzyme from Pseudomonas testosteroni. Biochem J. 1986 Mar 15;234(3):611–615. doi: 10.1042/bj2340611. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Haas D., Holloway B. W. R factor variants with enhanced sex factor activity in Pseudomonas aeruginosa. Mol Gen Genet. 1976 Mar 30;144(3):243–251. doi: 10.1007/BF00341722. [DOI] [PubMed] [Google Scholar]
  15. Hamzehpour M. M., Pechere J. C., Plesiat P., Köhler T. OprK and OprM define two genetically distinct multidrug efflux systems in Pseudomonas aeruginosa. Antimicrob Agents Chemother. 1995 Nov;39(11):2392–2396. doi: 10.1128/aac.39.11.2392. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Hancock R. E. W., Falla T. J. Antimicrobial peptides: broad-spectrum antibiotics from nature. Clin Microbiol Infect. 1996 Jun;1(4):226–229. doi: 10.1016/s1198-743x(15)60279-8. [DOI] [PubMed] [Google Scholar]
  17. Hancock R. E., Wong P. G. Compounds which increase the permeability of the Pseudomonas aeruginosa outer membrane. Antimicrob Agents Chemother. 1984 Jul;26(1):48–52. doi: 10.1128/aac.26.1.48. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Jarrell K., Kropinski A. M. The chemical composition of the lipopolysaccharide from Pseudomonas aeruginosa strain PAO and a spontaneously derived rough mutant. Microbios. 1977;19(76):103–116. [PubMed] [Google Scholar]
  19. Köhler T., Michéa-Hamzehpour M., Henze U., Gotoh N., Curty L. K., Pechère J. C. Characterization of MexE-MexF-OprN, a positively regulated multidrug efflux system of Pseudomonas aeruginosa. Mol Microbiol. 1997 Jan;23(2):345–354. doi: 10.1046/j.1365-2958.1997.2281594.x. [DOI] [PubMed] [Google Scholar]
  20. Labedan B. Increase in permeability of Escherichia coli outer membrane by local anesthetics and penetration of antibiotics. Antimicrob Agents Chemother. 1988 Jan;32(1):153–155. doi: 10.1128/aac.32.1.153. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Levy O. Antibiotic proteins of polymorphonuclear leukocytes. Eur J Haematol. 1996 May;56(5):263–277. doi: 10.1111/j.1600-0609.1996.tb00714.x. [DOI] [PubMed] [Google Scholar]
  22. Li X. Z., Livermore D. M., Nikaido H. Role of efflux pump(s) in intrinsic resistance of Pseudomonas aeruginosa: resistance to tetracycline, chloramphenicol, and norfloxacin. Antimicrob Agents Chemother. 1994 Aug;38(8):1732–1741. doi: 10.1128/aac.38.8.1732. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Li X. Z., Nikaido H., Poole K. Role of mexA-mexB-oprM in antibiotic efflux in Pseudomonas aeruginosa. Antimicrob Agents Chemother. 1995 Sep;39(9):1948–1953. doi: 10.1128/aac.39.9.1948. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Loh B., Grant C., Hancock R. E. Use of the fluorescent probe 1-N-phenylnaphthylamine to study the interactions of aminoglycoside antibiotics with the outer membrane of Pseudomonas aeruginosa. Antimicrob Agents Chemother. 1984 Oct;26(4):546–551. doi: 10.1128/aac.26.4.546. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Mermod N., Ramos J. L., Lehrbach P. R., Timmis K. N. Vector for regulated expression of cloned genes in a wide range of gram-negative bacteria. J Bacteriol. 1986 Aug;167(2):447–454. doi: 10.1128/jb.167.2.447-454.1986. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Morales V. M., Bäckman A., Bagdasarian M. A series of wide-host-range low-copy-number vectors that allow direct screening for recombinants. Gene. 1991 Jan 2;97(1):39–47. doi: 10.1016/0378-1119(91)90007-x. [DOI] [PubMed] [Google Scholar]
  27. Morrison D. C., Jacobs D. M. Binding of polymyxin B to the lipid A portion of bacterial lipopolysaccharides. Immunochemistry. 1976 Oct;13(10):813–818. doi: 10.1016/0019-2791(76)90181-6. [DOI] [PubMed] [Google Scholar]
  28. Nikaido H., Nikaido K., Harayama S. Identification and characterization of porins in Pseudomonas aeruginosa. J Biol Chem. 1991 Jan 15;266(2):770–779. [PubMed] [Google Scholar]
  29. Nikaido H., Rosenberg E. Y., Foulds J. Porin channels in Escherichia coli: studies with beta-lactams in intact cells. J Bacteriol. 1983 Jan;153(1):232–240. doi: 10.1128/jb.153.1.232-240.1983. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Nikaido H., Thanassi D. G. Penetration of lipophilic agents with multiple protonation sites into bacterial cells: tetracyclines and fluoroquinolones as examples. Antimicrob Agents Chemother. 1993 Jul;37(7):1393–1399. doi: 10.1128/aac.37.7.1393. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Nikaido H., Vaara M. Molecular basis of bacterial outer membrane permeability. Microbiol Rev. 1985 Mar;49(1):1–32. doi: 10.1128/mr.49.1.1-32.1985. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Ofek I., Cohen S., Rahmani R., Kabha K., Tamarkin D., Herzig Y., Rubinstein E. Antibacterial synergism of polymyxin B nonapeptide and hydrophobic antibiotics in experimental gram-negative infections in mice. Antimicrob Agents Chemother. 1994 Feb;38(2):374–377. doi: 10.1128/aac.38.2.374. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Ohsuka S., Ohta M., Masuda K., Arakawa Y., Kaneda T., Kato N. Lidocaine hydrochloride and acetylsalicylate kill bacteria by disrupting the bacterial membrane potential in different ways. Microbiol Immunol. 1994;38(6):429–434. doi: 10.1111/j.1348-0421.1994.tb01803.x. [DOI] [PubMed] [Google Scholar]
  34. Peterson A. A., Hancock R. E., McGroarty E. J. Binding of polycationic antibiotics and polyamines to lipopolysaccharides of Pseudomonas aeruginosa. J Bacteriol. 1985 Dec;164(3):1256–1261. doi: 10.1128/jb.164.3.1256-1261.1985. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Piers K. L., Brown M. H., Hancock R. E. Improvement of outer membrane-permeabilizing and lipopolysaccharide-binding activities of an antimicrobial cationic peptide by C-terminal modification. Antimicrob Agents Chemother. 1994 Oct;38(10):2311–2316. doi: 10.1128/aac.38.10.2311. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Plesiat P., Grandguillot M., Harayama S., Vragar S., Michel-Briand Y. Cloning, sequencing, and expression of the Pseudomonas testosteroni gene encoding 3-oxosteroid delta 1-dehydrogenase. J Bacteriol. 1991 Nov;173(22):7219–7227. doi: 10.1128/jb.173.22.7219-7227.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Plésiat P., Nikaido H. Outer membranes of gram-negative bacteria are permeable to steroid probes. Mol Microbiol. 1992 May;6(10):1323–1333. doi: 10.1111/j.1365-2958.1992.tb00853.x. [DOI] [PubMed] [Google Scholar]
  38. Poole K., Krebes K., McNally C., Neshat S. Multiple antibiotic resistance in Pseudomonas aeruginosa: evidence for involvement of an efflux operon. J Bacteriol. 1993 Nov;175(22):7363–7372. doi: 10.1128/jb.175.22.7363-7372.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. Richards R. M., Xing D. K. Investigation of synergism between combinations of ciprofloxacin, polymyxin, sulphadiazine and p-aminobenzoic acid. J Pharm Pharmacol. 1993 Mar;45(3):171–175. doi: 10.1111/j.2042-7158.1993.tb05527.x. [DOI] [PubMed] [Google Scholar]
  40. Richards R. M., Xing J. Z., Gregory D. W., Marshall D. Investigation of cell envelope damage to Pseudomonas aeruginosa and Enterobacter cloacae by dibromopropamidine isethionate. J Pharm Sci. 1993 Sep;82(9):975–977. doi: 10.1002/jps.2600820922. [DOI] [PubMed] [Google Scholar]
  41. Schröder G., Brandenburg K., Seydel U. Polymyxin B induces transient permeability fluctuations in asymmetric planar lipopolysaccharide/phospholipid bilayers. Biochemistry. 1992 Jan 28;31(3):631–638. doi: 10.1021/bi00118a001. [DOI] [PubMed] [Google Scholar]
  42. Smith A. W., Iglewski B. H. Transformation of Pseudomonas aeruginosa by electroporation. Nucleic Acids Res. 1989 Dec 25;17(24):10509–10509. doi: 10.1093/nar/17.24.10509. [DOI] [PMC free article] [PubMed] [Google Scholar]
  43. Stanier R. Y., Palleroni N. J., Doudoroff M. The aerobic pseudomonads: a taxonomic study. J Gen Microbiol. 1966 May;43(2):159–271. doi: 10.1099/00221287-43-2-159. [DOI] [PubMed] [Google Scholar]
  44. Vaara M. Agents that increase the permeability of the outer membrane. Microbiol Rev. 1992 Sep;56(3):395–411. doi: 10.1128/mr.56.3.395-411.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  45. Vaara M., Plachy W. Z., Nikaido H. Partitioning of hydrophobic probes into lipopolysaccharide bilayers. Biochim Biophys Acta. 1990 May 9;1024(1):152–158. doi: 10.1016/0005-2736(90)90218-d. [DOI] [PubMed] [Google Scholar]
  46. Viljanen P., Matsunaga H., Kimura Y., Vaara M. The outer membrane permeability-increasing action of deacylpolymyxins. J Antibiot (Tokyo) 1991 May;44(5):517–523. doi: 10.7164/antibiotics.44.517. [DOI] [PubMed] [Google Scholar]
  47. Viljanen P., Vaara M. Susceptibility of gram-negative bacteria to polymyxin B nonapeptide. Antimicrob Agents Chemother. 1984 Jun;25(6):701–705. doi: 10.1128/aac.25.6.701. [DOI] [PMC free article] [PubMed] [Google Scholar]
  48. Walker S. G., Beveridge T. J. Amikacin disrupts the cell envelope of Pseudomonas aeruginosa ATCC 9027. Can J Microbiol. 1988 Jan;34(1):12–18. doi: 10.1139/m88-003. [DOI] [PubMed] [Google Scholar]
  49. Weiss J., Beckerdite-Quagliata S., Elsbach P. Resistance of gram-negative bacteria to purified bactericidal leukocyte proteins: relation to binding and bacterial lipopolysaccharide structure. J Clin Invest. 1980 Mar;65(3):619–628. doi: 10.1172/JCI109707. [DOI] [PMC free article] [PubMed] [Google Scholar]
  50. Weiss J., Elsbach P., Shu C., Castillo J., Grinna L., Horwitz A., Theofan G. Human bactericidal/permeability-increasing protein and a recombinant NH2-terminal fragment cause killing of serum-resistant gram-negative bacteria in whole blood and inhibit tumor necrosis factor release induced by the bacteria. J Clin Invest. 1992 Sep;90(3):1122–1130. doi: 10.1172/JCI115930. [DOI] [PMC free article] [PubMed] [Google Scholar]
  51. Woodruff W. A., Hancock R. E. Construction and characterization of Pseudomonas aeruginosa protein F-deficient mutants after in vitro and in vivo insertion mutagenesis of the cloned gene. J Bacteriol. 1988 Jun;170(6):2592–2598. doi: 10.1128/jb.170.6.2592-2598.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  52. Yang T. Tetramethyl-p-phenylenediamine oxidase of Pseudomonas aeruginosa. Eur J Biochem. 1982 Jan;121(2):335–341. doi: 10.1111/j.1432-1033.1982.tb05791.x. [DOI] [PubMed] [Google Scholar]
  53. Zimmermann W., Rosselet A. Function of the outer membrane of Escherichia coli as a permeability barrier to beta-lactam antibiotics. Antimicrob Agents Chemother. 1977 Sep;12(3):368–372. doi: 10.1128/aac.12.3.368. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Bacteriology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES